ATP Synthesis-IN-3
CAT:
804-HY-149736
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

ATP Synthesis-IN-3
- CAS Number: 3032416-36-4
- UNSPSC Description: ATP Synthesis-IN-3 (compound 31) is an ATP hydrolysis inhibitor with protective effects during myocardial ischemia. ATP Synthesis-IN-3 can increase the ATP content of ischemic cardiomyocytes, increase the phosphorylation of PKA and phospholamban, and inhibit ischemia-induced apoptosis[1].
- Target Antigen: ATP Synthase; PKA
- Type: Reference compound
- Related Pathways: Membrane Transporter/Ion Channel;Stem Cell/Wnt;TGF-beta/Smad
- Applications: Neuroscience-Neuromodulation
- Field of Research: Cardiovascular Disease
- Assay Protocol: https://www.medchemexpress.com/atp-synthesis-in-3.html
- Solubility: 10 mM in DMSO
- Smiles: CN1CCN(C2=CC=C(NC3=NC(N4CCOCC4)=C5C(C(C6=CC=CC=C6)=NN5CC7=CC=C(C=C7)OC)=C3)C=C2)CC1
- Molecular Weight: 589.73
- References & Citations: [1]Nikolaou PE et al. Hydrolytic Activity of Mitochondrial F1FO-ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors. J Med Chem. 2023 Nov 23;66(22):15115-15140.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported